Hans Schoepflin

Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA.

Smedvig Capital Ltd (Smedvig Capital) is a private equity subsidiary of Smedvig Family founded in 1996 by Peter T. Smedvig and John Clinton Hewett. The firm is headquartered in London, United Kingdom.

LuMind IDSC Foundation engages in accelerate research to increase availability of therapeutic, diagnostic, and medical care options and will empower families through education, connections, and support. The company was founded on March 21, 2019 and is headquartered in Burlington, MA.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

HealthCap Partners LLC (HealthCap Partners) is a private equity firm founded in 1996 by Kip Weatherwax and Jason K. Dodd. The firm is headquartered in Dallas, Texas.

Venture Valuation VV AG is an independent research firm headquartered in Zurich, Switzerland. The firm was founded by Patrik Frei in 1999 and they provide independent assessment and valuation of companies, products and patents. Their focus is on technology companies in fast growing markets and industries including pharmaceuticals, Biotechnology, Medical Technology (Med Tech), nanotechnology, renewable energies (cleantech) and information technology (IT) / computer science / software. Venture Valuation’s clients include companies domiciled on almost all continents. The firm performs reviews both for investors as well as for companies themselves.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Murex Biotech Ltd. manufactures, designs and sells specialized products for the diagnosis of infectious diseases in the medical healthcare market. The company was incorporated on December 17, 1991 and is headquartered in Maidenhead, the United Kingdom.

Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.

Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million.

GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH.

Part of UCB SA, UCB Research, Inc. is a company that provides commercial physical research laboratory services. The company is based in Cambridge, MA.

Octagon Therapeutics, Inc. engages in the research and development of medicines based on novel metabolic targets in disease-causing bacteria, lymphocytes, and cancer cells. It develops a discovery platform that identifies novel therapeutic targets and small molecule inhibitors that are invisible in standard culture conditions. The company was founded by Fred Ausubel, Isaac Stoner, and Shen Yu in 2016 and is headquartered in Allston, MA.

Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark.

Smedvig Family Office provides investment services. It makes direct investments within property, private equity, and episodic/thematic investments. The company was founded in 1989 and is headquartered in Stavanger, Norway.

Smedvig AS performs investment portfolio services. The firm invests across a range of asset classes and has considerable experience in investing in the natural resources sector globally. It offers direct investments within property, private equity, episodic and thematic investments, and invests with private equity funds, long only funds, and hedge funds. The company was founded in 1989 and is headquartered in Stavanger, Norway.

Peder Smedvig Capital AS is an alternative investment manager. The company is based in Stavanger, Norway.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Part of Neumora Therapeutics, Inc., Alairion, Inc. is a company that develops novel chemo-protective medicinal products. The company is based in Cambridge, MA. Alairion was acquired by Neumora Therapeutics, Inc. on October 07, 2021.

Trefoil Ltd. operates as a holding company with interest in acquiring, exploring and developing and gas properties. The company was founded in November 13, 1997 and is headquartered in Buenos Aires, Argentina.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA.

Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT.

Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA.